Results 141 to 150 of about 11,390 (207)

Olmesartan Restores <i>LMNA</i> Function in Haploinsufficient Cardiomyocytes. [PDF]

Circulation
Kort EJ, Sayed N, Liu C, Mondéjar-Parreño G, Forsberg J, Eugster E, Wu SM, Wu JC, Jovinge S.   +8 more
europepmc   +1 more source

Integrating Experimental and Computational Approaches to Cardioprotection: Vascular Reactivity, Molecular Docking, and ADMET Modeling of <i>Melicoccus bijugatus</i> (Guinep). [PDF]

Int J Mol Sci
Logan K, Palacios J, Lopez S, Gray W, Nwokocha CR.   +4 more
europepmc   +1 more source

Zilebesiran-Small Interfering RNAs as Prospective New Drug in the Treatment of Hypertension. [PDF]

J Clin Med
Dudzicz-Gojowy S, Adamczak M.
europepmc   +1 more source

Effectiveness of single-pill combination olmesartan/amlodipine/hydrochlorothiazide therapy in patients with apparent resistant hypertension. [PDF]

J Hum Hypertens
Oh J, Kim W, Kim GH, Kim HL, Park SD, Min KW, Hyun D, Hong JH, Lim S, Bae JH, Shin J, RESOLVE-INT Investigators.   +11 more
europepmc   +1 more source

Rifampicin-induced challenges in managing endocrine hypertension and primary aldosteronism: a case report and literature review. [PDF]

Front Pharmacol
Song X, Jia M, Yu H, Dong Z, Cheok K, Pan X.   +5 more
europepmc   +1 more source

A Narrative Review on Nitrate-Rich Diets as Adjuncts to Antihypertensive Therapy: Enhancing Treatment Efficacy via Oxidative Stress Modulation. [PDF]

Biomedicines
Silva-Cunha M, Ceron CS, Moreno H, Tanus-Santos JE.   +3 more
europepmc   +1 more source

Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels. [PDF]

J Am Heart Assoc
Teramoto K, Nochioka K, Sakata Y, Nishimura K, Shimokawa H, Yasuda S, SUPPORT Trial Investigators *.   +6 more
europepmc   +1 more source

Investigation of hydrolysis of olmesartan medoxomil in different pH buffers by simultaneously measuring olmesartan medoxomil and olmesartan. [PDF]

PLoS One
Landry L, Dong X.
europepmc   +1 more source